VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ACET
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ACETAdicet Bio, Inc.
$8.56$80M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksACETQuarterly Financials

Adicet Bio, Inc. (ACET) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Adicet Bio, Inc. (ACET) quarterly income statement — complete revenue, gross profit & net income history

ACET Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue000000000000000024.99M5.47M3.43M4.81M
Revenue Growth %-------------100%-100%-100%-100%727.73%1.07%13.24%-35.51%
Cost of Goods Sold1.34M00000001.65M00000000000
COGS % of Revenue--------------------
Gross Profit-1.34M0000000-1.65M000000024.99M5.47M3.43M4.81M
Gross Margin %----------------100%100%100%100%
Gross Profit Growth %----100%--------100%-100%-100%-100%727.73%1.07%13.24%-35.51%
Operating Expenses20.23M31.89M27.95M32.39M29.89M30.74M33.15M32.85M29.22M31.57M52.26M34.89M33.32M31.57M22.98M22.71M20.28M21.01M17.14M15.64M
OpEx % of Revenue----------------81.17%384.24%499.82%324.91%
Selling, General & Admin4.08M6.85M5.1M3.97M7.07M7.47M6.9M6.95M5.32M6.81M6.63M6.53M6.57M6.55M6.42M6.53M6.8M6.35M5.21M5.03M
SG&A % of Revenue----------------27.21%116.17%152.03%104.38%
Research & Development17.49M25.04M22.85M28.42M22.81M23.27M26.25M25.9M23.9M24.76M26.17M28.36M26.76M25.02M16.57M16.18M13.48M14.66M11.93M10.62M
R&D % of Revenue----------------53.95%268.07%347.8%220.52%
Other Operating Expenses-1000K0000000001000K000000000
Operating Income-21.57M-31.89M-27.95M-32.39M-29.89M-30.74M-33.15M-32.85M-30.87M-31.57M-52.26M-34.89M-33.32M-31.57M-22.98M-22.71M4.71M-15.54M-13.71M-10.83M
Operating Margin %----------------18.83%-284.24%-399.82%-224.91%
Operating Income Growth %27.82%-3.72%15.69%1.39%3.19%2.61%36.56%5.85%7.36%-0%-127.37%-53.65%-808.07%-103.09%-67.65%-109.73%122.04%-66.24%-0.4%-25.46%
EBITDA-20.23M-30.41M-26.38M-30.74M-28.2M-29.12M-31.56M-31.25M-29.22M-29.88M-50.62M-33.38M-32.07M-30.51M-22.23M-22.3M5.06M-15.18M-13.32M-10.37M
EBITDA Margin %----------------20.24%-277.56%-388.51%-215.37%
EBITDA Growth %28.28%-4.44%16.42%1.63%3.47%2.53%37.65%6.39%8.88%2.06%-127.74%-49.67%-734.01%-101%-66.84%-115.1%124.05%-68%0.36%-24.66%
D&A (Non-Cash Add-back)1.34M1.47M1.57M1.66M1.68M1.62M1.59M1.6M1.65M1.69M1.65M1.51M1.25M1.06M759K405K352K365K388K459K
EBIT-21.57M-30.49M-26.84M-31.22M-28.21M-28.73M-30.48M-29.9M-28.01M-29.49M-49.88M-32.4M-30.86M-29.85M-21.98M-22.52M4.64M-15.54M-13.71M-10.83M
Net Interest Income1.32M1.5M1.16M1.4M1.68M2.07M2.73M3M2.92M2.18M2.52M2.61M2.65M2.15M1.21M307K14K12K-46K-42K
Interest Income1.34M1.52M1.17M1.4M1.68M2.07M2.73M3M2.92M2.18M2.52M2.62M2.67M2.18M1.22M325K32K37K4K9K
Interest Expense23K24K12K001K1K02K01K4K19K26K18K18K18K25K50K51K
Other Income/Expense1.33M1.37M1.1M1.18M1.67M2.02M2.67M2.95M2.85M2.08M2.38M2.49M2.44M1.69M989K169K-88K-260K-292K50K
Pretax Income-20.24M-30.52M-26.86M-31.22M-28.21M-28.73M-30.48M-29.9M-28.02M-29.49M-49.88M-32.4M-30.88M-29.88M-22M-22.54M4.62M-15.8M-14M-10.78M
Pretax Margin %----------------18.48%-288.99%-408.34%-223.87%
Income Tax0000000000000000011K11K77K
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%-0.07%-0.08%-0.71%
Net Income-20.24M-30.52M-26.86M-31.22M-28.21M-28.73M-30.48M-29.9M-28.02M-29.49M-49.88M-32.4M-30.88M-29.88M-22M-22.54M4.62M-15.81M-14.01M-10.85M
Net Margin %----------------18.48%-289.19%-408.66%-225.47%
Net Income Growth %28.25%-6.23%11.88%-4.4%-0.71%2.58%38.9%7.72%9.28%1.29%-126.79%-43.77%-768.71%-88.93%-56.97%-107.65%121.66%-76.52%5.18%-28.37%
Net Income (Continuing)-20.24M-30.52M-26.86M-31.22M-28.21M-28.73M-30.48M-29.9M-28.02M-29.49M-49.88M-32.4M-30.88M-29.88M-22M-22.54M4.62M-15.81M-14.01M-10.85M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.88-2.94-4.64-5.44-4.96-5.12-5.44-5.28-5.60-11.04-18.56-12.00-11.04-10.72-8.00-8.961.60-7.52-7.04-5.44
EPS Growth %62.1%42.58%14.71%-3.03%11.43%53.62%70.69%56%49.28%-2.99%-132%-33.93%-790%-42.55%-13.64%-64.71%112.2%-2.17%45%26.09%
EPS (Basic)-1.88-2.94-4.64-5.44-4.96-5.12-5.44-5.28-5.60-11.04-18.56-12.00-11.04-10.72-8.00-8.961.92-7.52-7.04-5.44
Diluted Shares Outstanding10.74M6.89M5.69M5.69M5.69M5.49M5.68M5.66M4.94M2.69M2.69M2.68M2.68M2.6M2.6M2.5M2.87M2.12M1.99M1.99M
Basic Shares Outstanding10.74M6.89M5.69M5.69M5.69M5.49M5.68M5.66M4.94M2.69M2.69M2.68M2.68M2.6M2.6M2.5M2.89M2.12M1.99M1.99M
Dividend Payout Ratio--------------------